Seguir
Patrick Kupelian
Patrick Kupelian
E-mail confirmado em mednet.ucla.edu
Título
Citado por
Citado por
Ano
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy
AJ Stephenson, SF Shariat, MJ Zelefsky, MW Kattan, EB Butler, BS Teh, ...
Jama 291 (11), 1325-1332, 2004
7632004
Radical prostatectomy, external beam radiotherapy< 72 Gy, external beam radiotherapy≥ 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for …
PA Kupelian, L Potters, D Khuntia, JP Ciezki, CA Reddy, AM Reuther, ...
International Journal of Radiation Oncology* Biology* Physics 58 (1), 25-33, 2004
6822004
Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results …
P Grimm, I Billiet, D Bostwick, AP Dicker, S Frank, J Immerzeel, M Keyes, ...
BJU international 109, 22-29, 2012
5982012
Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy
P Kupelian, T Willoughby, A Mahadevan, T Djemil, G Weinstein, S Jani, ...
International Journal of Radiation Oncology* Biology* Physics 67 (4), 1088-1098, 2007
5772007
Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer
TR Willoughby, PA Kupelian, J Pouliot, K Shinohara, M Aubin, M Roach III, ...
International Journal of Radiation Oncology* Biology* Physics 65 (2), 528-534, 2006
5142006
Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials
CR King, D Freeman, I Kaplan, D Fuller, G Bolzicco, S Collins, R Meier, ...
Radiotherapy and Oncology 109 (2), 217-221, 2013
4922013
A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer
I Cagiannos, P Karakiewicz, JA Eastham, M Ohori, F Rabbani, C Gerigk, ...
The Journal of urology 170 (5), 1798-1803, 2003
4852003
Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2
J Colon, N Hsieh, A Ferguson, P Kupelian, S Seal, DW Jenkins, CH Baker
Nanomedicine: Nanotechnology, Biology and Medicine 6 (5), 698-705, 2010
4492010
Observations on real-time prostate gland motion using electromagnetic tracking
KM Langen, TR Willoughby, SL Meeks, A Santhanam, A Cunningham, ...
International Journal of Radiation Oncology* Biology* Physics 71 (4), 1084-1090, 2008
4432008
Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience
PA Kupelian, TR Willoughby, CA Reddy, EA Klein, A Mahadevan
International Journal of Radiation Oncology* Biology* Physics 68 (5), 1424-1430, 2007
4372007
Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer
MW Kattan, MJ Zelefsky, PA Kupelian, PT Scardino, Z Fuks, SA Leibel
Journal of clinical oncology 18 (19), 3352-3359, 2000
4082000
Defining sexual outcomes after treatment for localized prostate carcinoma
LR Schover, RT Fouladi, CL Warneke, L Neese, EA Klein, C Zippe, ...
Cancer 95 (8), 1773-1785, 2002
4002002
Protection from radiation-induced pneumonitis using cerium oxide nanoparticles
J Colon, L Herrera, J Smith, S Patil, C Komanski, P Kupelian, S Seal, ...
Nanomedicine: Nanotechnology, Biology and Medicine 5 (2), 225-231, 2009
3732009
Long-term multi-institutional analysis of stage T1–T2 prostate cancer treated with radiotherapy in the PSA era
DA Kuban, HD Thames, LB Levy, EM Horwitz, PA Kupelian, AA Martinez, ...
International Journal of Radiation Oncology* Biology* Physics 57 (4), 915-928, 2003
3342003
Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study
AM Chen, C Felix, PC Wang, S Hsu, V Basehart, J Garst, P Beron, ...
The Lancet Oncology 18 (6), 803-811, 2017
3292017
Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical …
PA Kupelian, M Elshaikh, CA Reddy, C Zippe, EA Klein
Journal of clinical oncology 20 (16), 3376-3385, 2002
3242002
Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with Gleason score 9 …
AU Kishan, RR Cook, JP Ciezki, AE Ross, MM Pomerantz, PL Nguyen, ...
Jama 319 (9), 896-905, 2018
3212018
Monotherapy for stage T1–T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation
L Potters, EA Klein, MW Kattan, CA Reddy, JP Ciezki, AM Reuther, ...
Radiotherapy and Oncology 71 (1), 29-33, 2004
2862004
Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer
AU Kishan, A Dang, AJ Katz, CA Mantz, SP Collins, N Aghdam, FI Chu, ...
JAMA network open 2 (2), e188006-e188006, 2019
2752019
Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
PA Kupelian, J Katcher, HS Levin, EA Klein
International journal of radiation oncology, biology, physics 37 (5), 1043-1052, 1997
2691997
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20